Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dayton, OH
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lemon Grove, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Long Beach, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Burgas,
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Burgas,
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Washington,
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Washington,
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated:  12/31/1969
McLean Hospital
mi
from
Belmont, MA
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Charlestown, MA
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Charlestown, MA
Click here to add this to my saved trials
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Status: Enrolling
Updated:  12/31/1969
Segal Institute for Clinical Research 1201 North 37th Avenue
mi
from
Hollywood, FL
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Status: Enrolling
Updated: 12/31/1969
Segal Institute for Clinical Research 1201 North 37th Avenue
mi
from
Hollywood, FL
Click here to add this to my saved trials
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Miami, FL
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dayton, OH
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lemon Grove, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Burgas,
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Burgas,
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational site
mi
from
Culver City, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational site
mi
from
Culver City, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Glendale, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Torrance, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Anaheim, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational site
mi
from
Culver City, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational site
mi
from
Culver City, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Long Beach, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
National City, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
National City, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oakland, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oakland, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oceanside, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Pico Rivera, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Redlands, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Redlands, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials